The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
This application is a continuation of U.S. application Ser. No. 10/299,518, filed Nov. 19, 2002, now U.S. Pat. No. 6,833,384, which is a continuation of U.S. application Ser. No. 09/944,275, filed Aug. 31, 2001, now U.S. Pat. No. 6,552,065, which claims benefit of U.S. Provisional Application No. 60/229,943, filed Sep. 1, 2000, U.S. Provisional Application No. 60/292,232, filed May 18, 2001, and U.S. Provisional Application No. 60/307,490, filed Jul. 24, 2001.
